Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.530
-0.030 (-1.17%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Genelux Revenue
In the year 2025, Genelux had annual revenue of $8.00K. Genelux had revenue of $8.00K in the quarter ending December 31, 2025.
Revenue (ttm)
$8.00K
Revenue Growth
n/a
P/S Ratio
14,032.80
Revenue / Employee
$308
Employees
26
Market Cap
112.26M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seer, Inc. | 16.58M |
| Cibus | 3.64M |
| Cardiff Oncology | 593.00K |
| NeOnc Technologies Holdings | 39.99K |
| InflaRx | 34.44K |
GNLX News
- 5 weeks ago - Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners - GlobeNewsWire
- 3 months ago - Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 3 months ago - Genelux Corporation Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 4 months ago - Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer - GlobeNewsWire
- 6 months ago - Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 9 months ago - Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 10 months ago - Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - GlobeNewsWire